WOBURN, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new
technologies to create step-change improvements in crop yield that enhance global food security, today named Sherri M. Brown,
Ph.D., as a special commercial and technical advisor to the Company, effective immediately. Dr. Brown is currently managing
director of The Yield Lab, a global agrifood tech accelerator based in St. Louis. She previously served in a number of leadership
positions involving the development and global commercialization of new biotechnology traits for canola, soybean and corn at
Monsanto Company for 28 years.
“We are delighted to welcome Dr. Brown, an agricultural industry leader of tremendous caliber, to a crucial advisory role with
Yield10. She possesses a wealth of experience leading teams that have successfully developed and commercialized innovative
biotechnology traits globally in canola, soybean and corn,” said Oliver Peoples, Ph.D., president and chief executive officer of
Yield10. “Her extensive background in plant science, the assessment of yield traits in the field, global experience, and knowledge
of the commercial landscape will make her an invaluable resource for our team during this important period of our
growth.”
“The Yield10 team brings a differentiated approach and new insights to the identification of novel yield traits for commercial
food and feed crops, which has led to the discovery and evaluation of a remarkable pipeline of yield traits,” said Dr. Brown. “The
outcomes they have reported to date have been impressive, and I look forward to working with their team to contribute to the
Company's success.”
Dr. Brown joined The Yield Lab as Managing Director in 2017. From 1989 to 2017, she served in a number of leadership positions
at Monsanto, most involving the development and global commercialization of new traits for corn and oilseed crops including soybean
and canola. Dr. Brown most recently served as Vice President, Science Strategy at Monsanto from 2014 to 2017 and as a member of the
Monsanto Leadership Council. Prior to that, she was Vice President, Global Commercial Technology/Product Development from 2008 to
2014 where she was responsible for evaluating and launching the seed and trait pipeline, including eight new biotech traits. In
addition, she was Vice President, Technology, Global Corn Business (1999-2004) and Vice President, Technology, Oilseeds Business
team (1998-1999). Dr. Brown earned a Ph.D. at Indiana University, Bloomington, IN with a major in Genetics/Molecular, Cellular and
Developmental Biology. She earned a B.S. at Hope College, Holland, MI with a double major in Biology and Chemistry.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance
global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living
systems.Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and
the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several
yield traits it has developed in crops such as Camelina, canola, soybean and rice. Yield10 is headquartered in Woburn, MA and has
an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the company, please visit www.yield10bio.com.
(YTEN-G)
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this
press release which are not strictly historical, including, without limitation, those relating to the Company’s growth and the
potential for successful development and commercialization of new yield traits, constitute forward-looking statements. Such
forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially
from those anticipated, including the risks and uncertainties detailed in Yield10 Bioscience's filings with the Securities and
Exchange Commission. Yield10 assumes no obligation to update any forward-looking information contained in this press release or
with respect to the matters described herein.
Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Media Inquiries:
Eric Fischgrund
Fischtank Marketing and PR
eric@fischtankpr.com
Investor Relations:
Bret Shapiro
Managing Director, CORE IR
561-479-8566, brets@coreir.com
